Related Experiment Video
Updated: Aug 11, 2026
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
[Maxillary ameloblastoma: report of two cases]
M F García Reija1, M Izquierdo, J A Blanco Rueda
1Servicio Regional de Cirugía Maxilofacial, Hospital Universitario del Río Hortega, C/Cardenal Torquemada s/n. 47010 Valladolid.
Acta Otorrinolaringologica Espanola
|August 31, 2001
Summary
Maxillary ameloblastomas, aggressive benign tumors, show higher relapse rates and malignancy risk than mandibular ones. Their location near critical structures increases surgical complexity and potential for spread.
Area of Science:
- Odontogenic Tumors
- Oral Pathology
- Maxillofacial Surgery
Background:
- Ameloblastomas are locally aggressive benign odontogenic tumors.
- 15-20% of ameloblastomas occur in the maxilla.
Observation:
- Maxillary ameloblastomas exhibit a worse prognosis compared to mandibular tumors.
- These tumors present higher rates of postsurgical relapse and increased malignancy potential.
- Proximity to the nasal cavity, orbit, and skull base poses a risk of local invasion.
Findings:
- Maxillary ameloblastomas are associated with poorer outcomes.
- Higher recurrence rates and increased risk of malignant transformation are noted.
- The anatomical location presents significant challenges due to potential extension.
Implications:
- Surgical management of maxillary ameloblastomas requires careful consideration of anatomical proximity.
- Early detection and aggressive treatment may be crucial for improving patient outcomes.
- Further research into tailored therapeutic strategies for maxillary ameloblastomas is warranted.
